(1)
To Evaluate the Efficacy of Teneligliptin As an Add-on Therapy in Type 2 Diabetes Mellitus (T2DM) Patients With Inadequate Glycemic Control With a Stable Dose of Metformin 1 to 2g and Glimipride 1 to 6mg Per Day . AJM 2024, 4 (2), 61-66. https://doi.org/10.48165/sjmv1n60.